Navigation Links
Anthrax stops body from fighting back, study shows

University of Florida researchers have uncovered how the inhaled form of anthrax disarms bacteria-fighting white blood cells before they can fend off the disease, which kills most victims within days.

The lethal toxin in anthrax paralyzes neutrophils, the white blood cells that act as the body's first defense against infection, by impairing how they build tiny filaments that allow them to crawl throughout the body and eat invading bacteria.

Just two hours of exposure to the lethal toxin blocks the neutrophils' ability to produce these filaments by nearly 60 percent, paralyzing themand allowing the anthrax to move freely in the body, according to research released last week in The Journal of Infectious Diseases.

The need to find new ways to treat victims of bioterrorism has increased since the Sept. 11, 2001, terrorist attacks and the anthrax attacks that killed five people exposed to inhalation anthrax through the mail. The UF findings could lead to treatments that block anthrax from paralyzing the much-needed neutrophils, said Dr. Frederick Southwick, division chief of infectious diseases at the UF College of Medicine and the lead author of the paper.

"If your neutrophils work normally, you might be able to shut down thisinfection," said Southwick, who worked on the study with a team of UF researchers and investigators from the Centers for Disease Control and Prevention and Emory University. "The overall goal is to understand how anthrax toxins paralyze the immune system."

Researchers first noticed anthrax's effect on these white blood cells while reviewing the cases in the 2001 anthrax attacks.

The victims did not have elevated white blood cell counts, typical for most infections, and a large number of the inhaled anthrax bacteria had spread from the lungs into the bloodstream, which is unusual, Southwick said.

This led researchers to believe anthrax may be impairing the cells' ability to move and fight off t
'"/>

Source:University of Florida


Page: 1 2 3

Related biology news :

1. Study Models Impact Of Anthrax Vaccine
2. Anthrax test, developed by army and CDC, receives FDA approval
3. Anthrax inhibitors identified by Burnham team
4. Anthrax spores may survive water treatment
5. Anthrax inhibitor counteracts toxin, may lead to new therapeutics
6. Anthrax attack posed greater potential threat than thought
7. Anthrax paralyzes immune cells with lethal toxin, UF research shows
8. One bacteria stops another on contact
9. New compound stops brain cell degeneration in Alzheimers disease
10. RNA interference stops colon cancer spread in mice
11. Insulin receptor stops progression of Alzheimers disease

Post Your Comments:
(Date:11/23/2009)...s. November 23, 2009 Applied mathematicians diss...lancifolia ), a characteristic long leaf with a sa...s along the edges. The simple cause of the lily,s ...nding during differential growthwas revealed by us...ibbons. , Haiyi Liang, a postdoctoral student at...
(Date:11/23/2009)...More than 160 participants gathered this week for ... INITIATIVE conference. This year,s topic, "Synthe...rs, and medical researchers to explore the enginee...e emerging field of synthetic biology. , Bonnie ...ceton University and this year,s conference chair,...
(Date:11/23/2009)... only swine vaccine available for the H1N1 virus h...th the virus. The vaccination marks the first time...ith the pandemic flu., Iowa State University,s H... the vaccine this summer and has been shipping pre...nd Illinois for several weeks., The latest vacci...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B 28R 29 49981 1Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B 28R 29 49981 2Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita based Center of Excellence with Global Convenience 28TM 29 12775 1Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita based Center of Excellence with Global Convenience 28TM 29 12775 2Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita based Center of Excellence with Global Convenience 28TM 29 12775 3Migraine Frequency Tied to Stroke Heart Attack Risk 49976 1Migraine Frequency Tied to Stroke Heart Attack Risk 49976 2Migraine Frequency Tied to Stroke Heart Attack Risk 49976 3
...trains of influenza showed genetic differences fro...virus flu shot was found to be effective in preven...ted-virus nasal spray vaccine also prevented illne...determined by laboratory confirmation of flu infec...rlier studies had suggested that the nasal spray, ...
...n to eat their fruit and vegetables. But once kids...ften go the way of Barbie dolls and power rangers.... fruits past adolescence. , Fisetin, a naturally o...and other fruits and vegetables, stimulates signal... researchers at the Salk Institute for Biological ...
...fornia, San Diego (UCSD) School of Medicine ? www.... the world to self-report adverse effects of stati... "This line of research is important because many ...cholesterol are familiar with the benefits of stat...r with the adverse experiences with these drugs th...
Other Biology News:Flu shot effective against drifted influenza, nasal spray vaccine less so 2Flu shot effective against drifted influenza, nasal spray vaccine less so 3A natural chemical found in strawberries boosts memory in healthy mice 2A natural chemical found in strawberries boosts memory in healthy mice 3Patients can report statins' adverse effects on new web site 2
(Date:11/27/2009)..., PARIS, November 27 /PRNewswire-FirstCall/...l to market Oralair(R) in both adults and children...the first country where,Oralair(R) has been market...lair(R) is now registered in Austria, Belgium, Bul..., Germany, Greece, Hungary, Ireland, Italy,Latvia...
(Date:11/25/2009)... , BOSTON, Nov. 25 Biotech...virus, genomic data from the 1918 pandemic through...rent H1N1 pandemic, today issued its latest bioche...at the lethality of the H1N1 ("Swine Flu") virus h...the virus,s current outbreak in the spring of 2009...
(Date:11/25/2009)... , BEIJING, Nov. 25 /PRNewswire-Asia/...er and provider of vaccines, announced today that ...blish Sinovac (Dalian) Vaccine,Technology Co., Ltd... produce,and commercialize human-use vaccines. Sin...in developing and commercializing world-class vacc...
(Date:11/24/2009)... , HOUSTON, Nov. 24 /PRNewswire-FirstCall/ -...r of electrical and communications systems and ser...al markets, announced today that its commercial bu...attan Torcon JV to install the electrical systems ... facility at the U.S. Army Medical Research Instit...
Breaking Biology Technology:STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
...launch..., WAYLAND, Mass., March 20 Tourtellotte...clinical trials software, announces the,launch of ...orm for phase,II-IV studies. Trident,s unique para... of legacy IVRS technologies and promises to deliv...and ease-of-use to the straining,global clinical I...
...Inc., a,pioneer in drug discovery from marine micr... begun in a Phase 1b study evaluating the vascular...th standard chemotherapy,in patients with non-smal...positive outcomes in a Phase 1 single-agent clinic...harmacodynamics (PK/PD) and efficacy of NPI-2358,i...
...ian acceptance of electrophysiology ablation as...lation, according to Millennium Research Group, W...esearch Group,s Global Markets for Atrial Fibrilla...00 electrophysiology (EP) procedures were,performe... procedure,volumes will increase at a compound ann...
Other Biology Technology:Tourtellotte's New Trident IWR(TM) Eliminates 12-Week Study Setup Lead Time for Clinical Trials 2Tourtellotte's New Trident IWR(TM) Eliminates 12-Week Study Setup Lead Time for Clinical Trials 3Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data 2Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data 3Electrophysiology Procedures for Atrial Fibrillation Treatment to Grow Over 25% Annually Over the Next Five Years 2
Safety Glasses Dispensers from Terra Universal, Inc.
Dispensing Bins from Terra Universal, Inc.
...cept that it uses a deep-UV deuterium bulb, which ...ith a shutter (controlled via a TTL signal or swit... powerful, stable output from 215-400 nm. In addit...lable, providing a wavelength range of 190-400 nm....
...sis and mitochondrial membrane potential. The mito...n early indication of the initiation of cellular a...ollapse in the electrochemical gradient across the... in the membrane potential (YD). Loss of mitochond...
Biology Products: